Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

European equity markets may thrive with monetary easing, fiscal expansion, and controlled inflation, despite risks from ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary - The World Economic ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward ...